ArticlePolymers2025
Printability and Performance Metrics of New-Generation Multifunctional PMMA/Antibacterial Blend Nanocomposites in MEX Additive Manufacturing.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poly(methyl methacrylate) (PMMA) is a thermoplastic widely utilized in civilian-, defense-, and medicine-related applications. Therefore, inducing antibacterial properties is an additional asset when infection control is prioritized. To counter this, PMMA was mixed, for the first time, with antibacterial agents (antibacterial blend nanopowder, AP) to curb bacterial proliferation and therefore reduce the chances of infection. The reinforcing efficacy of the blend in PMMA was also assessed. Nanocomposites were developed with various nanopowder concentrations for 3D printing material extrusion (MEX). PMMA/AP nanocomposites were evaluated for their mechanical and rheological properties, thermal stability, morphological, structural, and chemical characteristics, and bacterial resistance (against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.